NRD
VSTM icon

Nebula Research & Development’s Verastem VSTM Stock Holding History

Nebula Research & Development’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,689
Closed -$52.7K – 860
2025
Q2 		$52.7K Buy
+12,689
New +$79.5K ﹤0.01% 934

Other funds holding VSTM

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nebula Research & Development's VSTM Position: Q3 2025 in Review

Nebula Research & Development sold out of Verastem (VSTM) in Q3 2025, closing a stake of 12,689 shares — an estimated $52.7K sold.

Nebula Research & Development first reported a position in VSTM in Q2 2025 and held it in 1 quarter. The position peaked at $52.7K in Q2 2025. 117 funds tracked by Wall St. Rank hold VSTM as of Q3 2025.

  • Nebula Research & Development reported no remaining Verastem position as of Q3 2025 after selling out during the quarter.
  • Nebula Research & Development sold 12,689 Verastem shares in Q3 2025, an estimated $52.7K.
  • Nebula Research & Development first reported a position in Verastem in Q2 2025 and held it in 1 quarter.
  • Nebula Research & Development's Verastem position peaked at $52.7K in Q2 2025.
  • 117 funds tracked by Wall St. Rank held Verastem as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.